BioCryst Pharmaceuticals
BCRX
#5046
Rank
$1.08 B
Marketcap
$5.26
Share price
-0.19%
Change (1 day)
-38.04%
Change (1 year)

Operating Margin for BioCryst Pharmaceuticals (BCRX)

Operating Margin as of May 2024 (TTM): -77.02%

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -77.02%. At the end of 2021 the company had an Operating Margin of -115.68%.

Operating Margin history for BioCryst Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-115.68%-88.73%
2020-1,026.35%360.27%
2019-222.99%-54.52%
2018-490.25%87.7%
2017-261.18%24.82%
2016-209.25%134.73%
2015-89.15%-73.16%
2014-332.08%91.15%
2013-173.72%16.88%
2012-148.64%-48.73%
2011-289.91%426.4%
2010-55.08%199.04%
2009-18.42%-61.65%
2008-48.03%5.99%
2007-45.31%-94.01%
2006-756.28%-95.77%
2005-17,895.15%177.17%
2004-6,456.46%730.7%
2003-777.23%-16.69%
2002-932.91%1987.87%
2001-44.68%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
26.84%-134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
22.54%-129.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
-88.19% 14.50%๐Ÿ‡บ๐Ÿ‡ธ USA
27.34%-135.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-149.57% 94.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,520.92% 1,874.71%๐Ÿ‡บ๐Ÿ‡ธ USA
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
-5,975.84% 7,658.82%๐Ÿ‡บ๐Ÿ‡ธ USA
17.53%-122.76%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.